7/6:In the case Association for Molecular Pathology v. Myriad Genetics, Inc. (2013), the U.S. Supreme Court held that under U.S. Patent Laws, isolated DNA is:

not eligible for patent protection because it is human-made.

eligible for patent protection because it is naturally occurring.

eligible for patent protection because it is human-made.

not eligible for patent protection because it is naturally occurring.